Baxter International Inc (NYSE:BAX)
| 38.12 Delayed Data As of Mar 23 |  -0.005 / -0.01%Today’s Change | 37.35 Today|||52-Week Range 80.72 | -25.22% Year-to-Date |
Latest BAX News | Press Releases
| Wall Street Is Bullish on GE HealthCare as It Invests in AI Mar 20 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 38.12 |
| Today’s open | 39.34 |
| Day’s range | 38.09 - 39.34 |
| Volume | 4,855,043 |
| Average volume (3 months) | 5,995,666 |
| Market cap | $19.4B |
Data as of 4:00pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -288.73% |
| Earnings growth (this year) | -18.23% |
| Earnings growth (next 5 years) | -1.88% |
| Revenue growth (last year) | +18.22% |
| P/E ratio | NM |
| Price/Sales | 1.70 |
| Price/Book | 3.32 |
Competitors
| ---- | ||
| PODDInsulet Corp | -3.67 | -1.16% |
| SAUHFStraumann Holding AG | +4.28 | +3.09% |
| WSTWest Pharmaceutical ... | -0.06 | -0.02% |
Data as of 4:00pm ET, 03/23/2023
Financials
| Next reporting date | April 27, 2023 |
| EPS forecast (this quarter) | $0.48 |
| Annual revenue (last year) | $15.1B |
| Annual profit (last year) | -$2.4B |
| Net profit margin | -16.10% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Deerfield, Illinois |
Forecasts
